Industry News – BioCrossroads

FOR IMMEDIATE RELEASE
Thursday, Aug. 27, 2026

Bristol Myers Squibb expansion set to create high-wage jobs, advance radiopharmaceutical innovation in Indiana

INDIANAPOLIS – Indiana Governor Mike Braun today announced RayzeBio, Inc., a Bristol Myers Squibb Company, plans to significantly expand its life sciences footprint in Indiana, further solidifying the state’s reputation as the Radiopharmaceutical Capital of the World . The company will further its investment in its radiopharmaceutical manufacturing operations, establishing a new facility in Whitestown and creating up to 100 new, high-wage jobs at its Indianapolis and planned Whitestown locations by the end of 2029.

“As a state, we are investing in our life sciences sector like never before, with plans to invest $1 billion and create 100,000 new jobs over the next 10 years,” said Gov. Braun. “RayzeBio’s expansion and planned job creation will contribute to this growth, advancing life-changing solutions used across the world while creating even more high-wage career opportunities that allow Hoosiers to thrive.”

Bristol Myers Squibb, through RayzeBio, a clinical-stage life sciences company, expects to invest more than $173 million in its central Indiana operations, establishing an approximately 450,000-square-foot, state-of-the-art facility at the Anson Industrial Park in Boone County. The company’s expected expansion will grow its capacity to produce the next generation of radiopharmaceutical therapies (RPTs), which use radioisotopes to target and deliver internal radiation to cancer cells while seeking to reduce risk to the surrounding organs and healthy tissues, potentially delivering a better outcome for patients living with cancer.

The new facility, which is expected to begin construction this year, will complement RayzeBio’s current 77,000-square-foot RPT supply and manufacturing operation on the northeast side of Indianapolis, which is built to support clinical and commercial supply across the United States and worldwide. The company plans to hire for advanced manufacturing roles at both of its facilities, with average annual wages expected to exceed $130,000 annually.

“Indiana is an important part of our strategy to build the infrastructure needed to advance the next generation of radiopharmaceutical therapies,” said Ben Hickey, president of RayzeBio. “This investment expands our manufacturing capabilities, creates high-quality jobs, and strengthens our ability to deliver innovation for patients. We’re proud to grow our presence in Indiana and contribute to the state’s emergence as a leading hub for life sciences manufacturing.”

California-based RayzeBio was established in 2020 with the mission to advance cancer treatment and transform people’s lives. The company, which was acquired by Bristol Myers Squibb in 2024, is focused on advancing actinium-based RPTs and a pipeline of investigational drug development programs with the potential to be first-in-class and best-in-class. Current programs are aimed at addressing several types of solid tumors, including gastroenteropancreatic neuroendocrine tumors (GEP-NET), liver and prostate cancers.

RayzeBio’s expansion in Indiana supports the state’s efforts to build on its recognition as the Radiopharmaceutical Capital of the World, and is expected to support the Governor’s life sciences initiative – a commitment to investing $1 billion over 10 years in agricultural and life sciences to make Indiana the premier destination for human, animal and plant health. As part of this effort, the state is positioning the BioHeartland for new expansions and investments with the goal of creating 100,000 new jobs.

– 30 –

FOR IMMEDIATE RELEASE
Aug. 25, 2026

First INCAP apprentices start working at employers throughout the state

New pathway prepares students for in-demand jobs

The first high school students participating in the Indiana Career Apprenticeship Pathway (INCAP) are beginning their apprenticeships as schools across the state start the new academic year. Fifty sophomores and juniors will be INCAP apprentices at 25 employer locations across 15 communities statewide. (See list below of participating employers and schools).

INCAP is a new education and training pathway that prepares Hoosiers for in-demand careers and helps Indiana businesses find and train employees. INCAP is for high school and adult students, with adult career training programs starting later this fall.
Participating high schoolers split their time between the workplace and the classroom, spending multiple full days a week on the job to help ensure they gain in-demand skills while also making meaningful contributions to their employers. The students are paid by their employers and work year-round.

This year, the 50 high schoolers participating in INCAP are enrolled in one of six Apprenticeship Programs:

In Advanced Manufacturing and Logistics, four students are participating in the Polymechanic Apprenticeship Program.
In Banking/Financial Services, 25 students are participating in the Retail Banking Apprenticeship Program.
In Healthcare, 16 students are participating in the Healthcare Assistant Apprenticeship Program.
In Tech/IT, three students are participating in the IT Project Coordinator Apprenticeship Program, one is in the IT Support Technician Apprenticeship Program, and one is in the Software Development Associate Apprenticeship Program.

“Thousands of in-demand jobs across Indiana are waiting to be filled, and INCAP is a game-changing way to help students prepare for those opportunities,” said David Becker, CEMETS iLab Indiana co-chair and chairman and CEO of First Internet Bank, which hired three INCAP apprentices this school year. “With more than 100,000 new jobs expected in Indiana by 2033, we cannot afford to leave talent on the sidelines. Programs like INCAP connect students to meaningful careers while giving employers access to the workforce they need for the future.”

“In addition, not enough Hoosiers get the education and training needed after high school to meet labor market needs. By 2031, 72% of U.S. jobs will require some form of education or training beyond high school, and Indiana is not on track to meet that workplace reality,” said Claire Fiddian-Green, president & CEO of the Richard M. Fairbanks Foundation and co-chair of CEMETS iLab Indiana, the coalition of Hoosier leaders building INCAP.

INCAP increases options for Hoosiers
The new pathway’s combination of real-world skills training and classroom learning creates more opportunities for Hoosiers to prepare for their future career.

INCAP aligns with Indiana’s new high school diploma requirements, as the pathway provides a structure for students to earn at least 650 hours of work-based learning and a Credential of Value, which are requirements of the new Employment Honors Plus Seal. High schoolers will earn an INCAP credential or degree, while adults who complete an INCAP training program will earn an INCAP degree.

INCAP degrees and credentials are recognized as indicators of industry experience and hold value in the job market, so INCAP apprentices are prepared to enter the job market or pursue college. INCAP degrees and credentials will also count toward college credit in related degree programs across Indiana.

This recognition is enabled by the new Indiana Qualifications Framework, which aligns degrees and credentials earned in INCAP (and other work-based learning pathways) with academic programs and is overseen by the new Indiana Qualifications Advisory Panel (IQAP). After the IQAP coordinates an independent review process that includes industry experts and the Indiana Office of Education gives final approval, INCAP credentials are added to the state’s Credentials of Value list.

As a result, students can more easily transition between INCAP and the college pathway because the education and training they complete in the workplace is recognized for credit.

Looking ahead
Recruitment for the next cohort of INCAP apprentices will begin in January 2027. For the 2027-2028 school year, more than 15 apprenticeship occupations are expected to be available across eight industries with significant workforce needs: Advanced Manufacturing and Logistics, Banking/Financial Services, Construction, Healthcare, Hospitality, Insurance, Life Sciences, and Tech/IT.

Background
The Fairbanks Foundation is funding the creation and launch of INCAP, while CEMETS iLab Indiana — a coalition of more than 300 Hoosier leaders from various industries, K-12 schools, higher education, nonprofits, government, and philanthropic organizations — is leading the effort. Since 2016, the Fairbanks Foundation has awarded more than $25 million in grants to support youth apprenticeship pilot programming and the new education and training pathway now known as INCAP.

Modeled on a world-class system that has prepared Swiss youth and adults for careers since the 1970s, INCAP equips students and adults with the skills they need to succeed in the 21st century workplace and provides employers in key industries with the workers they need to compete on a global scale. iLab leaders have set an ambitious goal for the Indiana Career Apprenticeship Pathway: to provide education and training to 50,000 Hoosiers by 2034.

List of 2026-27 INCAP apprentices
The employers that have hired at least one INCAP apprentice by Aug. 19, 2026, are listed below.

Industry	Occupation	Employer	Apprenticeship Location	Apprentice’s Year in School	Apprentice’s High School
AML	Polymechanic	Medartis	Warsaw	11^th	Triton in Bourbon
AML	Polymechanic	Medartis	Warsaw	11^th	Triton in Bourbon
AML	Polymechanic	PRD	Springville	11^th	Mitchell in Mitchell
AML	Polymechanic	PRD	Springville	11^th	Bedford North Lawrence in Bedford
Banking	Retail Banker	Citizens State Bank	New Castle	11^th	New Castle
Banking	Retail Banker	Citizens State Bank	New Castle	11^th	New Castle
Banking	Retail Banker	First Bank Midwest	Frankfort	11^th	Clinton Prairie
Banking	Retail Banker	First Federal Savings Bank	Rochester	11^th	Rochester
Banking	Retail Banker	First Internet Bank	Fishers	11^th	Hamilton Southeastern
Banking	Retail Banker	First Internet Bank	Fishers	11^th	Hamilton Southeastern
Banking	Retail Banker	First Internet Bank	Fishers	11^th	Hamilton Southeastern
Banking	Retail Banker	First Merchants Bank	Indianapolis	11^th	Lawrence Central
Banking	Retail Banker	First Merchants Bank	Indianapolis	11^th	Lawrence North
Banking	Retail Banker	First Merchants Bank	Plainfield	11^th	Plainfield
Banking	Retail Banker	First Merchants Bank	Zionsville	11^th	Zionsville
Banking	Retail Banker	First State Bank of Middlebury	Middlebury	11^th	Northridge
Banking	Retail Banker	HomeBank	Martinsville	11^th	Martinsville
Banking	Retail Banker	Hoosier Heartland State Bank	Crawfordsville	11^th	Crawfordsville
Banking	Retail Banker	Lake City Bank	Warsaw	11^th	Warsaw
Banking	Retail Banker	Lake City Bank	Warsaw	11^th	Warsaw
Banking	Retail Banker	The National Bank of Indianapolis	Indianapolis	11^th	Shortridge
Banking	Retail Banker	New Washington State Bank	Charlestown	11^th	Charleston
Banking	Retail Banker	Old National Bank	Evansville	11^th	North
Banking	Retail Banker	Old National Bank	Evansville	11^th	North
Banking	Retail Banker	Old National Bank	Evansville	11^th	North
Banking	Retail Banker	Old National Bank	Evansville	11^th	Harrison
Banking	Retail Banker	Old National Bank	Evansville	11^th	Bosse
Banking	Retail Banker	Old National Bank	Evansville	11^th	Reitz
Banking	Retail Banker	Old National Bank	Evansville	11^th	New Tech Institute
Healthcare	Healthcare Assistant	Community Health Network	Indianapolis	10^th	Lawrence Central
Healthcare	Healthcare Assistant	Community Health Network	Indianapolis	10^th	Lawrence Central
Healthcare	Healthcare Assistant	Community Health Network	Indianapolis	10^th	Lawrence North
Healthcare	Healthcare Assistant	Community Health Network	Indianapolis	10^th	Lawrence North
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Tecumseh in Lynnville
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Tecumseh in Lynnville
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Tecumseh in Lynnville
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Tecumseh in Lynnville
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Tecumseh in Lynnville
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Bosse
Healthcare	Healthcare Assistant	Deaconess Midtown	Evansville	10^th	Central
Healthcare	Healthcare Assistant	IU Health Methodist	Indianapolis	10^th	Believe Circle City
Healthcare	Healthcare Assistant	IU Health Methodist	Indianapolis	10^th	Purdue Polytechnic
Healthcare	Healthcare Assistant	IU Health Paoli	Paoli	10th	Students will come from Shoals, Mitchell, and/or Orleans high schools
Healthcare	Healthcare Assistant	IU Health Paoli	Paoli	10th	Students will come from Shoals, Mitchell, and/or Orleans high schools
Healthcare	Healthcare Assistant	IU Health Paoli	Paoli	10th	Students will come from Shoals, Mitchell, and/or Orleans high schools
Tech/IT	IT Project Coordinator	AvantBlue (Butler)	Indianapolis	11^th	Believe Circle City
Tech/IT	IT Project Coordinator	EmployIndy	Indianapolis	11^th	Lawrence Central
Tech/IT	IT Support Technician	Indianapolis Airport Authority	Indianapolis	11^th	Plainfield
Tech/IT	IT Project Coordinator	TechIndiana	Fishers	11^th	Lawrence North
Tech/IT	Software Development Associate	Tenon	Indianapolis	11^th	Homeschool

About INCAP
INCAP is a new education and training pathway that prepares Hoosiers for in-demand careers and helps Indiana businesses find and train employees. INCAP offers programs for high school and adult students, with the first high school apprenticeships launching for the 2026-2027 school year, while career training programs for adults begin later this fall. INCAP participants split their time between the workplace and the classroom, spending multiple full days a week on the job to help ensure they gain in-demand skills while also making meaningful contributions to their employers. INCAP participants are paid by their employers and work year-round.

After completing an INCAP program, graduates can decide to enter the workforce or attend college. If they launch a career, they’re prepared to enter an in-demand field and have the option to continue industry-led education and training within INCAP. If they go to college, they may be able to complete a college degree in fewer years because INCAP degrees and credentials in related fields are recognized as college credit. For more information, visit IndianaCAP.org.

# # #

MEDIA CONTACTS:
Jen Schmits Thomas, JTPR, (317) 441-2487, [email protected]
Andrea Farmer, Richard M. Fairbanks Foundation, (317) 663-4198, [email protected]

INDIANAPOLIS (August 12, 2026) – BioCrossroads today announced the charter members of Indiana’s Life Sciences Industry Talent Association (ITA), an employer-led body that will help define occupational standards and build industry-aligned training pathways for the state’s growing life sciences sector.

Ten employers – three founding members, Eli Lilly and Company, Novartis, and RayzeBio, a Bristol Myers Squibb Company, and seven members, Boston Scientific, Elanco, Evonik, INCOG BioPharma Services, Stevanato Group, Simtra BioPharma Solutions, and BioConverence LLC dba Singota Solutions – have joined the Life Sciences ITA, united by a shared commitment to ensuring Indiana has the skilled workforce its life sciences industry needs to grow, compete, and continue leading the nation.

BioCrossroads serves as the designated ITA for life sciences within the Indiana Career Apprenticeship Pathway (INCAP), a statewide, employer-led education and training pathway that connects classroom learning with paid, on-the-job training beginning in high school and continuing into adult career advancement. Through INCAP, the various industry-specific ITAs give employers within specific sectors a direct role in identifying priority occupations, defining the skills and competencies those roles require, and shaping the training programs that education and workforce partners deliver.

“Indiana is a critical part of the future of pharmaceutical manufacturing and building that future requires building upon the investments in facilities and technologies to train a highly skilled workforce prepared to support the safe, reliable production of medicines for patients,” said Edgardo Hernandez, executive vice president and president, manufacturing operations, Eli Lilly and Company. “The Life Sciences ITA gives large and small employers a direct role in shaping the training pathways needed to prepare that workforce, creating new opportunities for Hoosiers while strengthening Indiana’s leadership in life sciences manufacturing.”

The Life Sciences ITA’s first priority occupation is a Life Sciences Operator, a foundational role responsible for supporting pharmaceutical and biomanufacturing production environments. Life Sciences Operators help monitor and maintain the equipment used to manufacture medicines in highly regulated settings, ensuring processes meet rigorous quality and safety standards. The role is accessible to candidates with a high school diploma, making it a meaningful entry point into the sector with well-paying wages and clear pathways for career advancement. The Life Sciences ITA plans to launch pilot apprenticeship opportunities for this role in fall 2027.

“Ensuring a sustainable pipeline of talent is key to Novartis’s global workforce strategy and we are proud to be part of bringing Swiss-style apprenticeships to Indiana,” said Rheyan Cader, global head of people & organization, RLT operations / U.S. operations P&O head, Novartis. “As Indiana’s life sciences sector continues to grow, partnerships like this are essential to expanding access to meaningful career pathways and developing the skilled talent needed to support advanced manufacturing, innovation, and long-term industry growth.”

The announcement comes at a moment of significant momentum for Indiana’s life sciences sector and its identity as BioHeartland – the bioscience ecosystem connecting human health, animal health, and plant science innovation across the full journey to invent, make and move life-changing products. Indiana is the nation’s top exporter of life sciences and pharmaceutical products and home to more than 3,300 life sciences establishments employing approximately 70,000 Hoosiers. Together, these companies and their employees generate more than $100 billion in annual economic activity. Demand for skilled talent, including entry-level production and manufacturing roles, continues to outpace supply. Industry projections estimate a need for 2,400 to 3,700 new biomanufacturing employees per year over the next decade in Indiana alone.

“Indiana’s life sciences sector is strong and enjoying tremendous growth. To sustain that growth depends in large part on a workforce pipeline built around the needs of employers,” said Melanie Vuynovich, senior director of life sciences at BioCrossroads, and the leader of the Life Sciences ITA. “The Life Sciences ITA gives industry leaders a direct role in defining what workforce readiness means for life sciences occupations, from the skills required on day one to the training models needed for long-term career growth. As BioHeartland continues to attract global investment and industry growth, developing and retaining world-class talent remains critical to the region’s long-term competitiveness and economic vitality.”

The Life Sciences ITA will operate within Indiana’s growing life sciences workforce ecosystem and through affiliations with other workforce initiatives such as BioTrain, the biomanufacturing training effort established through the Heartland BioWorks Tech Hub, a $51 million project supported by the U.S. Economic Development Administration and led by the Applied Research Institute in collaboration with BioCrossroads, Purdue University, Ivy Tech Community College, and Employ Indy. BioTrain will participate in the Life Sciences ITA to coordinate respective efforts to align training curricula, share employer-defined competency standards, and expand the pipeline of job-ready talent for Indiana’s life sciences and biomanufacturing industries.

Life sciences companies operating in Indiana, or those considering a presence in the state, are encouraged to join the Life Sciences ITA. ITA Membership gives organizations a direct voice in creating and defining the occupational pathways and standards that will shape Indiana’s next generation of life sciences talent. To learn more or express interest in joining, contact BioCrossroads at biocrossroads.com/incap.

###

About BioCrossroads

BioCrossroads is a catalyst for Indiana’s diverse and growing life sciences industry, supporting collaboration, expertise, and investments that fuel innovation and transform global health. An initiative of the CEOs of Corporate Partnership (CICP), BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting corporate, academic, and philanthropic partners; facilitating investments in promising startups; building new enterprises; and educating through conferences, reports, and market insights. For more information, visit biocrossroads.com.

About INCAP

The Indiana Career Apprenticeship Pathway (INCAP) is a statewide initiative that creates new pathways for high school students and adults to train for in-demand careers while helping Indiana employers build the talent pipelines they need to grow. The INCAP Apprenticeship Program (INCAP AP) offers multi-year apprenticeships beginning in high school, combining classroom learning with paid on-the-job training. The INCAP Career Program (INCAP CP) offers industry-led programs for adults. Both programs are anchored by Industry Talent Associations, employer-led bodies that define the occupations, skills, and training needed to meet current and future workforce demand. This work is supported by the Richard M. Fairbanks Foundation. For more information, visit indianacap.org.

Advancing a new model for musculoskeletal innovation

Led by Indiana University and supported by more than 170 partners, the statewide initiative will connect research, industry, clinical care, data, and talent to move new technologies to patients and markets faster.

Indiana has spent decades building one of the most concentrated and globally significant musculoskeletal health sectors in the nation. Now, a major National Science Foundation investment will help the state turn that strength into the next generation of technologies, companies, and patient care.

Indiana is among the 12 regions nationwide selected for the NSF Regional Innovation Engines program. Led by Indiana University, the NSF IMPACT Engine in Indiana will connect orthopedic manufacturers, research universities, health systems, clinicians, data resources, and economic development partners to accelerate musculoskeletal innovation from discovery to market.

The Engine will receive $15 million during its first two years, with the potential to receive up to $160 million from NSF over the next decade as it reaches established milestones.

A national investment in regional strengths

A recent Brookings Institution analysis places Indiana’s selection within a broader shift in how the United States invests in innovation and economic competitiveness.

Established through the CHIPS and Science Act of 2022, the NSF Regional Innovation Engines program is designed to help regions build internationally competitive technology clusters by connecting research with private industry, talent development, entrepreneurship, and commercialization.

Rather than attempting to create innovation clusters from the ground up, these place-based investments build on regional capabilities that are already established and ready to scale. Brookings identified Indiana among the regions positioned to advance national bioscience and biomanufacturing priorities through this latest round of federal investment.

The state is home to one of the world’s most concentrated orthopedic medical device industries, leading research universities, major health systems, advanced manufacturing capabilities, and a growing network of entrepreneurs and investors. The NSF IMPACT Engine is designed to connect those assets more intentionally, creating clearer pathways from discovery to clinical validation, product development, manufacturing, and adoption.

Building upon a statewide partnership

The NSF IMPACT Engine builds on the Indiana Musculoskeletal Health Partnership for the Advancement of Care and Treatment, or IMPACT. The partnership had already convened more than 170 collaborators across Indiana before the NSF selection.

The coalition includes partners from industry, healthcare, higher education, research, workforce development, and government. Eli Lilly and Company, Zimmer Biomet, OrthoWorx, IU Health, Regenstrief Institute, Purdue University, the University of Notre Dame, and BioCrossroads are among the organizations involved.

OrthoWorx brings deep connections to the orthopedic industry in Warsaw and Kosciusko County. Its ongoing work in talent development, talent attraction, and innovation will help connect the statewide initiative with one of the world’s most concentrated orthopedic manufacturing communities.

Moving from designation to implementation

Nearly half of Americans live with a chronic musculoskeletal disorder, including conditions such as arthritis and osteoporosis. Musculoskeletal injuries and conditions can affect a person’s mobility, ability to work, independence, and overall quality of life.

The NSF IMPACT Engine will bring clinicians, engineers, researchers, and industry partners together to address these challenges. Its work will include artificial intelligence and machine learning applications, biosensors, digital twin technology, clinical validation, commercialization support, and workforce development.

The coalition also plans to develop what is intended to become the world’s largest integrated musculoskeletal dataset. That resource could support the development of new therapies, smarter implants, and faster diagnostic tools.

Over the longer term, the coalition aims to train more than 1,900 workers, launch more than 85 startups, bring at least 30 innovations to market, and generate more than $535 million in economic impact for Indiana. These are stated goals for the initiative, with continued NSF funding dependent on its progress during the first two years.

As a partner in the NSF IMPACT Engine, BioCrossroads will work alongside Indiana University, OrthoWorx, industry leaders, research institutions, health systems, and organizations across the state to support its implementation.

The award gives Indiana an opportunity to build on an industry it already leads, strengthen connections across the state, and bring more musculoskeletal innovations from research to the people who need them.

ARCS Foundation Expands National Scholar Award Program to Indiana

Indiana’s life sciences ecosystem is built around a rare combination of strengths: global companies, research universities, innovation districts, manufacturing scale, logistics infrastructure, and a statewide network of partners working across human health, animal health, and plant science.

Now, a national scholarship program focused on advancing scientific talent is expanding into that ecosystem.

ARCS Foundation will host the ARCS National Scholar Award Inaugural Ceremony on September 2, 2026, at the Purdue University Memorial Union in West Lafayette, to introduce Indiana leaders to the ARCS National Scholar Award Program and its new partnership with Purdue University. The event will also give ARCS Foundation an opportunity to learn more about Indiana’s life sciences economy and the industry partners whose work is helping shape the future of health, research, technology, and manufacturing.

The Purdue partnership marks the first expansion of the ARCS National Scholar Award Program into Indiana. Through the agreement, ARCS will provide ongoing private, unrestricted funding for Purdue doctoral students conducting research in high impact and emerging technology fields. Initial support will focus on biomedical engineering, electrical and computer engineering, and mechanical engineering.

That connection matters for Indiana.

Across the state, life sciences companies and research institutions are advancing work in pharmaceuticals, medical technology, diagnostics, animal health, plant science, manufacturing, logistics, data, and next generation technologies. Purdue’s role in the ARCS National Scholar Award Program adds another point of connection between graduate research, industry need, and long-term talent development.

ARCS Foundation has supported scientific talent for more than 65 years by providing financial awards to academically outstanding U.S. citizens pursuing graduate degrees in science, engineering, math, technology, and medical research. The National Scholar Award Program was created to expand ARCS support into regions not currently served by ARCS chapters and to invest in scientific fields important to U.S. competitiveness.

For Indiana, the opportunity is both immediate and long term.

The event will introduce industry leaders to a national model for supporting doctoral scholars while giving ARCS Foundation a closer look at the companies, institutions, and innovation assets that make Indiana a leading life sciences state. It is also a chance to begin building the relationships needed to grow scholarship support in Indiana over time.

Private, unrestricted support gives scholars the flexibility to stay focused on research, pursue promising ideas, and continue work that may one day contribute to new discoveries, technologies, companies, and solutions. For industry partners, that kind of investment strengthens the research and talent pipeline that helps Indiana compete.

As ARCS Foundation begins its work in Indiana, BioCrossroads encourages life sciences leaders, employers, investors, and philanthropic partners to attend, learn more, and help connect the program to the broader ecosystem.

Indiana has the industry base. Purdue brings world-class research strength. ARCS brings a national model for investing in scientific talent. Together, they create a new opportunity to support the next generation of researchers whose work can help move Indiana’s life sciences economy forward.

Support scientific talent in Indiana

Companies and philanthropic partners interested in supporting ARCS scholars in Indiana can learn more at the event and begin exploring how private support can help strengthen Indiana’s research, innovation, and life sciences talent pipeline.

Contact:

Nancy Chambers

ARCS Foundation National Board of Directors

Chair, ARCS National Scholar Program

nchambers@arcsfoundation.org

404.593.4474

Attend the ARCS Foundation event

Industry leaders, employers, investors, academic partners, and philanthropic organizations are invited to attend the ARCS National Scholar Award Inaugural Ceremony to learn more about ARCS Foundation, the National Scholar Award Program, and the program’s first Indiana partnership with Purdue University.

Event: ARCS National Scholar Award Inaugural Ceremony
Date: September 2, 2026
Time: 3:00-5:00 p.m.
Location: Purdue University Memorial Union
Hosted by: ARCS Foundation
Registration: Scan the QR code to the right or click the button below.

bio international convention 2026

Highlights from the Indiana Pavilion

Indiana returned to BIO International with a coordinated statewide presence for the first time in six years, bringing together companies, universities, innovation districts and industry partners inside the Indiana Pavilion.

Across four days at Booth 3143, BioCrossroads helped lead conversations focused on the full arc of Indiana’s bioscience economy. Partners discussed how innovation districts are creating places for collaboration, how research institutions and industry anchors are moving discoveries toward commercial impact, and how Indiana’s manufacturing, logistics, and workforce assets support companies building and scaling in the state.

The week also marked the national introduction of BioHeartland Indiana, giving partners a shared platform to tell a more unified story about the state’s strengths across human health, animal health and plant science.

Explore the photo gallery, partner highlights, and on-site interviews from BIO International 2026.

Partners at BIO 2026

Indiana’s presence at BIO International 2026 was shaped by partners working across the full bioscience economy, from research and commercialization to innovation districts, manufacturing, logistics, workforce development and business growth. At Booth 3143, that meant more than representing individual organizations. Together, Indiana Pavilion partners showed how the state’s bioscience ecosystem works in practice.

BioCrossroads is grateful to each partner who helped bring Indiana’s bioscience story to BIO International and helped introduce BioHeartland Indiana to a national audience.

Discover
BioHeartland Indiana

BioHeartland Indiana is the shared identity for Indiana’s statewide bioscience ecosystem, connecting strengths across human health, animal health and plant science.

See how companies, universities, research institutions, innovation districts and industry partners are connected across the state.

New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs.

INDIANAPOLIS, June 22, 2026 /PRNewswire/ — Today at BIO International Convention in San Diego, the CEOs of Indiana Corporate Partnership announced the bioscience sector across Indiana will now be known as “BioHeartland Indiana.”

For more than a century, Indiana’s life sciences ecosystem has been inventing, making and moving bioscience solutions at global scale across human health, animal health and plant science. The state’s leading role in the GLP-1 revolution is a tangible example of what’s possible when discovery, research, development, manufacturing and distribution exist within a single connected ecosystem.

With Eli Lilly, Elanco Animal Health, and Corteva, the region is home to global leaders in human health, animal health, and plant science. The state’s four R1 universities, the nation’s largest medical school, and the Indiana Bioscience Research Institute, combined with the industry researchers, serve to generate 3x the national average for issued patents. The biosciences sector contributes over $100B of economic activity to the state.

“Indiana is a powerhouse in human, animal and plant biosciences, but our story has not been told with the clarity, consistency or urgency it deserves,” said Melina Kennedy, CEO of the CEOs of Indiana Corporate Partnership. “What makes this region different is not just that we make bioscience solutions, we are also a hotbed of invention and discovery, with the manufacturing strength, logistics infrastructure and collaborative spirit to move innovations into the world. BioHeartland gives us a shared identity to help investors, companies and talent understand the full value of what Indiana offers.”

The announcement follows Governor Mike Braun’s $1 billion commitment to help Indiana’s life sciences companies accelerate growth over the next ten years.

“People will hear the words ‘BioHeartland Indiana’ and automatically think, “that’s a place open for science and innovation where industry professionals across the entire value chain deliver solutions in a practical, collaborative way, enabling companies to move with speed from lab to market,” said Vince Wong, president and CEO of BioCrossroads, a non-profit organization that grows, advances, and invests in Indiana’s life sciences and healthcare sectors. “When it comes to biosciences, people will think of Indiana the same as Boston, the Research Triangle of North Carolina, or even international locations like Zurich and Basel.”

Indiana’s bioscience industry currently generates more than $125 billion in annual economic impact and leads the nation in both life sciences and pharmaceutical exports.

BIO International Convention

Fifteen BioHeartland Indiana partners are attending BIO International including: Eli Lily and Company, Elanco Animal Health, 16 Tech Innovation District, One Health Innovation District, Genezen, Heartland BioWorks Tech Hub powered by the Applied Research Institute, Indiana Biosciences Research Institute, Indiana Economic Development Corporation, IU Launch Accelerator for Biosciences, Indiana Life Sciences Association, Indy Partnership, Langham Logistics and Purdue University. BioCrossroads is leading BioHeartland Indiana’s presence at BIO International Convention.

BioHeartland Indiana is located at Booth 3134 and will host a series of in-booth conversations designed to give BIO attendees a closer look at the people, places and capabilities behind Indiana’s life sciences momentum. A schedule of events and details about BioHeartland’s presence at BIO International can be found on the organization’s website.

About BioHeartland Indiana
BioHeartland Indiana is a shared identity led by the CEOs of Central Indiana Corporate Partnership (CICP), in collaboration with its branded initiatives, BioCrossroads and AgriNovus Indiana, and in partnership with the Central Indiana Regional Development Authority (CIRDA). It exists to amplify Indiana’s bioscience strengths, while elevating the innovation districts, companies and research centers inventing, making and moving a rare concentration of life-changing innovation across human, animal and plant health at global scale. Learn more at INBioHeartland.com.

About CICP
The CEOs of Indiana Corporate Partnership (CICP) was formed in 1999 (under its legal name, Central Indiana Corporate Partnership) to bring together the chief executives of the region’s prominent corporations, foundations and universities in a strategic and collaborative effort dedicated to Indiana’s continued prosperity and growth. To advance this objective, CICP sponsors five key talent and industry sector initiatives, AgriNovus Indiana, Ascend Indiana, BioCrossroads, Conexus Indiana, and TechPoint, each of which addresses challenges and opportunities unique to its respective area: agbiosciences, talent and workforce development, life sciences, advanced manufacturing and logistics, and technology. To learn more about CICP, visit cicpindiana.com.

About AgriNovus Indiana
AgriNovus Indiana, a branded initiative of the CEOs of Indiana Corporate Partnership (CICP), is a nonprofit organization focused on advancing the agbioscience sector by connecting and convening stakeholders to deliver innovative ways to inspire and attract agbiosciences talent, companies and innovation to the state. Learn more at www.AgriNovusIndiana.com.

About BioCrossroads
An initiative of the CEOs of Indiana Corporate Partnership (CICP), BioCrossroads is a catalyst for Indiana’s life sciences sector, advancing the state’s position as a global leader in research, development, manufacturing, and healthcare innovation. Through strategic initiatives, industry partnerships, and ecosystem development, BioCrossroads supports the growth of life sciences companies, talent, and investment, as well as existing enterprises and new business development across Indiana. The initiative fosters public-private collaboration by uniting a diverse range of academic, industry, and philanthropic stakeholders, all collectively focused on advancing Indiana’s life sciences sector. To learn more about BioCrossroads, visit biocrossroads.com.

Media Contact:
Joe Morgan
Sōvyn
[email protected]

SOURCE BioHeartland Indiana

IBJ BioFutures 2026 spotlights Indiana’s life sciences momentum

Indiana’s life sciences story is one of discovery, production, talent, investment, and impact. The 2026 edition of IBJ BioFutures offers a closer look at that story and the people, companies, institutions, and ideas helping shape what comes next.

Published by the Indianapolis Business Journal, BioFutures highlights the breadth of Indiana’s life sciences sector and the role it plays in advancing health, strengthening the economy, and positioning the state for continued growth. This year’s issue explores themes that are central to Indiana’s life sciences leadership, from pediatric innovation and national health security to the sector’s broader contribution to jobs, investment, and well-being.

For BioCrossroads, the publication reflects the story we see across the ecosystem every day: Indiana is a place where research, manufacturing, logistics, workforce development, and industry collaboration come together in ways that create real opportunity. The state’s life sciences sector is not defined by a single company, campus, or region. It is a connected statewide ecosystem with global companies, emerging startups, research universities, innovation districts, hospitals, service providers, and workforce partners all contributing to its strength.

That connection is what makes Indiana’s life sciences sector distinctive. Ideas can move from the lab to commercialization. Products can be made, scaled, and shipped. Talent can find pathways into high-impact careers. Companies can grow in an environment built around collaboration, infrastructure, and long-term sector focus.

BioFutures also arrives at an important moment for Indiana. As the state continues to elevate its life sciences identity through BioHeartland, the publication helps bring visibility to the industries and institutions driving progress across human health, animal health and plant science. It gives readers a clear view of why Indiana matters in the global life sciences economy and why the work happening here has an impact far beyond the state’s borders.

BioHeartland at BIO International 2026

As Indiana’s biosciences ecosystem continues to expand and become more connected across research, commercialization, manufacturing, logistics, and talent, BioCrossroads will lead a coordinated state presence at BIO International 2026 to show how that momentum is taking shape across BioHeartland.

Indiana sits at the intersection of human health, animal health, and plant science. The state is home to a rare concentration of expertise where breakthrough science creates real-world impact. Over the past six years, that foundation has evolved from a series of individual assets into a connected, statewide bioscience ecosystem now unified under a single identity, BioHeartland.

Today, Indiana’s bioscience industry generates more than $125 billion in direct economic impact statewide and since 2024, has been leading the nation in both life sciences and pharmaceutical exports.

Innovation districts are bringing companies, universities, researchers, and entrepreneurs into the same orbit. Research institutions have put more focus behind commercialization. Companies have expanded across discovery, manufacturing, and logistics. Talent programs have grown to meet the needs of an industry scaling quickly.

From June 22-25, BioCrossroads will lead a statewide presence at BIO International 2026 that shows how that momentum is taking shape across BioHeartland.

The Indiana Pavilion will bring together the bioscience companies, universities, innovation districts, and ecosystem partners that reflect the full strength of BioHeartland, from discovery and commercialization to advanced manufacturing, specialized logistics, talent, and global industry leadership.

Together, these partners show how Indiana’s bioscience ecosystem works in practice, connecting the people, places, and capabilities that help companies discover, develop, manufacture, and deliver what comes next across human health, animal health, and plant science.

Meet the partners bringing the BioHeartland to BIO

16 Tech Innovation District
16 Tech is one of Indiana’s key innovation districts, bringing together companies, researchers, entrepreneurs, and partners in a place designed to make collaboration easier and more productive.

Elanco and One Health Innovation District
Elanco’s global headquarters anchors the One Health Innovation District, a platform for collaboration across human, animal, plant, and environmental health.

Eli Lilly and Company
Headquartered in Indianapolis, Lilly brings global life sciences leadership and a long-standing Indiana presence across discovery, development, and manufacturing.

Genezen
Based in Fishers, Genezen supports viral vector development and manufacturing for cell and gene therapy companies, representing Indiana’s growing strength in advanced therapies.

Heartland BioWorks Tech Hub Powered by the Applied Research Institute
Heartland BioWorks is strengthening Indiana’s biomanufacturing ecosystem by connecting industry, research institutions and government partners around next-generation biotechnology, workforce development, and pathways that help prepare talent for highly technical roles..

Indiana Biosciences Research Institute (IBRI)
IBRI connects academic, clinical, and industry partners around major health challenges, with research focused on areas including metabolic disease, Alzheimer’s disease, and pediatric rare diseases.

Indiana Economic Development Corporation
IEDC supports Indiana’s statewide economic development strategy, helping companies understand the opportunities, resources, and partnerships available to grow in the state.

IU Launch Accelerator for Biosciences (IU LAB)
Established by Indiana University and under development at 16 Tech Innovation District, IU LAB is focused on advancing biosciences entrepreneurship, industry partnerships, talent development, and university-connected commercialization.

Indiana Life Sciences Association
Indiana Life Sciences Association is the state’s life sciences trade association, connecting, promoting and advocating for organizations across Indiana’s life sciences industry and helping companies access the relationships, resources and policy support needed to grow.

Indy Partnership
Indy Partnership supports business growth and attraction across the Indianapolis region, helping connect companies with the regional assets, partners, and opportunities that support life sciences growth.

Langham Logistics
Langham Logistics brings specialized supply chain and cold-chain expertise to the pavilion, including a major pharmaceutical cold-chain facility in Plainfield.

Purdue University
Purdue brings deep research and commercialization strengths across human health, animal health, plant science, agriculture, engineering, and entrepreneurship.

Conversations at the Indiana Pavilion

Throughout the week, BioCrossroads will host a series of in booth conversations designed to give BIO attendees a closer look at the people, places, and capabilities behind Indiana’s life sciences momentum.

Monday, June 22

“Indiana’s Innovation Districts: Meet the Life Sciences Hubs”

Featuring leaders from One Health Innovation District, 16 Tech Innovation District, and BioHeartland. The conversation will explore how Indiana’s innovation districts are connecting researchers, companies, manufacturers and investors to build one of the country’s most dynamic life sciences ecosystems.

Tuesday, June 23

“From Discovery to Market: Indiana’s Innovation Story”

Bringing together leaders from the Indiana Biosciences Research Institute, Purdue University, and Lilly to discuss how Indiana’s research institutions are turning scientific strength into commercial impact. The conversation will focus on what makes Indiana one of the most productive innovation ecosystems in the country and what is coming next.

Wednesday, June 24

“#1 in Pharma Exports: Indiana’s Manufacturing Advantage”

Spotlighting Genezen, Heartland BioWorks, and Langham Logistics, three organizations working on the front lines of Indiana’s manufacturing, workforce and supply chain capabilities. The discussion will go behind the numbers to explore what Indiana’s manufacturing ecosystem looks like on the ground and what it means for companies looking to build and scale in Indiana.

Connect with Indiana at BIO

For those attending BIO International, the Indiana Pavillion will offer a direct look at the companies, institutions, and partners helping shape one of the country’s most active bioscience economies.

Inside Booth 3143, attendees will find partners working across the full life sciences value chain, from research and commercialization to innovation districts, advanced manufacturing, specialized logistics, workforce development, and business growth. Together, they reflect how Indiana’s strengths are becoming more connected and how the state is supporting life sciences companies at every stage of growth.

BioCrossroads will help bring that story forward in San Diego, connecting companies, investors, researchers, and partners with the people and places shaping what comes next for Indiana’s life sciences ecosystem.

Visit BioCrossroads and Indiana’s bioscience ecosystem partners at Booth 3143 at BIO International 2026 in San Diego.

Learn more at INBioHeartland.com.

New regional identity showcases the state’s ability to invent, make and move breakthroughs across human health, animal health and plant science, positioning Indiana to compete globally for bioscience investment, innovation and talent.

INDIANAPOLIS (May 19, 2026) — Today, regional leaders introduced BioHeartland, a new shared identity designed to unify and elevate Indiana’s bioscience ecosystem across human health, animal health and plant science.

Developed through a collaborative effort led by the CEOs of Indiana Corporate Partnership (CICP) and its branded initiatives, BioCrossroads and AgriNovus Indiana, in partnership with the Central Indiana Regional Development Authority, BioHeartland was created to give Indiana a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world.

For more than a century, Indiana has steadily helped shape global health through leadership in research, development, manufacturing and logistics – inventing, making and moving bioscience solutions at global scale. Today, the state’s bioscience industry generates more than $125 billion in direct economic impact, ranks first in the nation for pharmaceutical and life sciences exports and continues to attract companies, talent and investment at an accelerating pace.

As Indiana competes globally for the next generation of bioscience jobs, companies and innovation, leaders across industry, academia and economic development are coming together around a unified identity for the region’s bioscience ecosystem.

“Indiana’s life sciences sector has reached a remarkable level of scale because of decades of collaboration across industry, academia, government, philanthropy and investors,” said Vince Wong, president and CEO of BioCrossroads. “BioHeartland helps connect that story across research, development, manufacturing, talent and entrepreneurship, and gives us a clearer way to show how Indiana’s life sciences ecosystem is producing real results for people here and around the world.”

“Indiana is home to global leaders in human, animal and plant health – a powerful intersection for innovation and our competitive advantage,” said Christy Wright, president and CEO of AgriNovus Indiana. “BioHeartland tells our connected story, showing the state’s ability to bring new solutions to market that address critical needs for farmers, consumers and communities across the world.”

Indiana’s bioscience industry generates more than $125 billion in direct economic impact. The state ranks first in the nation for pharmaceutical and life science exports, and Hoosier inventors have patented more than 13,000 inventions since 2010, nearly three times the national average. Governor Mike Braun has also committed $1 billion over the next decade to grow high wage jobs in agriculture and life sciences, further strengthening Indiana’s position in plant, animal and human health.

“Governor Braun’s $1 billion commitment to creating 100,000 new jobs is a statement to the world: Indiana is planting a flag in the ground as the place for human, animal and plant health,” said David Adams. “The assets are already here — from discovery to delivery — across one connected region. With this announcement, Central Indiana has a unified voice and a stronger platform to compete globally for investment, companies and talent. Now it’s time to tell the BioHeartland story to the world.”

The BioHeartland launch also builds on the state’s broader regional growth strategy, including Governor Braun’s designation of CIRDA to help lead and coordinate the next phase of bioscience growth across Indiana.

That economic strength is rooted in a rare concentration of expertise. Indiana is one of the few places in the world where human health, animal health and plant science all operate at scale in the same region. Global companies including Eli Lilly and Company, Elanco and Corteva are headquartered or deeply rooted in Indiana, alongside a growing network of startups, research institutions and advanced manufacturing operations.

“Indiana’s bioscience strength is the result of decades of investment, collaboration, and innovation operating in close proximity,” said David A. Ricks, chair and CEO of Eli Lilly and Company. “Lilly has been a proud part of the BioHeartland story for 150 years, and we’re just getting started.”

“Creating BioHeartland further advances the efforts to make Indiana a premiere destination for life sciences talent and innovation,” said Jeff Simmons, president and CEO of Elanco. “We believe BioHeartland will accelerate efforts to build an ecosystem where the next generation of life-changing bioscience innovation will be created. We look forward to contributing to and thriving within this exciting new chapter.”

Indiana’s research universities are also central to BioHeartland’s ecosystem, producing and attracting the talent that powers the region’s innovation pipeline while advancing discoveries that reach patients, farmers and communities around the world. The state is home to four R1 research universities, including the largest medical school in the country.

“BioHeartland reflects Indiana’s extraordinary capacity to develop and deliver bioscience solutions at scale,” said IU President Pamela Whitten. “From our nine campuses to initiatives like the IU Launch Accelerator for Biosciences, Indiana University is proud to contribute to that leadership ecosystem through research and innovation that’s improving lives and driving economic opportunity across our state.”

“With our strengths in human, animal and plant health research and innovation, Purdue University is deeply connected to this ecosystem,” said Mung Chiang, president of Purdue University. “BioHeartland gives that work a shared identity and a platform to further accelerate innovation in this space in central Indiana.”

The BioHeartland identity also reflects the growing network of innovation districts and bioscience hubs across Central Indiana, including 16 Tech Innovation District, the LEAP Innovation District, the OneHealth Innovation District, and the Fishers Life Sciences and Innovation District. Together, those districts form a connected constellation designed to help ideas move faster from discovery to commercialization by bringing together research, talent, manufacturing capacity and infrastructure.

“Communities across Indiana have spent years investing in life sciences infrastructure and innovation,” said Fishers Mayor Scott Fadness, chair of the Central Indiana Regional Development Authority. “BioHeartland gives the entire region a unified way to tell our story to position ourselves as a life science destination that can compete globally.”

BioHeartland will make its international debut at the BIO International Convention in San Diego, June 22 through 25, where Indiana leaders will introduce the identity to global investors, companies and bioscience partners. Brand assets, messaging guidance and partner resources are available at INBioHeartland.com.

###

About BioHeartland
BioHeartland is a shared identity led by the CEOs of Central Indiana Corporate Partnership (CICP), in collaboration with its branded initiatives, BioCrossroads and AgriNovus Indiana, and in partnership with the Central Indiana Regional Development Authority (CIRDA). It exists to amplify Indiana’s bioscience strengths, while elevating the innovation districts, companies and research centers making and moving a rare concentration of life-changing innovation across human, animal and plant health at global scale. Learn more at INBioHeartland.com.

About CICP
CEOs of Indiana Corporate Partnership (CICP) was formed in 1999 (under its legal name, Central Indiana Corporate Partnership) to bring together the chief executives of the region’s prominent corporations, foundations and universities in a strategic and collaborative effort dedicated to Indiana’s continued prosperity and growth. To advance this objective, CICP sponsors five key talent and industry sector initiatives, AgriNovus Indiana, Ascend Indiana, BioCrossroads, Conexus Indiana, and TechPoint, each of which addresses challenges and opportunities unique to its respective area: agbiosciences, talent and workforce development, life sciences, advanced manufacturing and logistics, and technology. To learn more about CICP, visit cicpindiana.com.

About AgriNovus
AgriNovus Indiana, a branded initiative of the CEOs of Indiana Corporate Partnership (CICP), is a nonprofit organization focused on advancing the agbioscience sector by connecting and convening stakeholders to deliver innovative ways to inspire and attract agbiosciences talent, companies and innovation to the state. Learn more at www.AgriNovusIndiana.com.

See the full announcement from the May 19 launch of BioHeartland

Watch the BioHeartland launch event, including remarks from industry and state leaders, the unveiling of BioHeartland and the story behind why this shared identity matters as Indiana works to tell a stronger, more unified story about its ability to invent, make and move bioscience innovation at scale across human health, animal health and plant science.

Speakers include:

Vince Wong, President and CEO, BioCrossroads
Christy Wright, President and CEO, AgriNovus Indiana
Melina Kennedy, CEO, Central Indiana Corporate Partnership
David Adams, Indiana Secretary of Commerce
Scott Fadness, Mayor, City of Fishers